Visible benefits on ischemic patients: Cardiac imaging
About the event
In this conference, the doctor Luis Antonio Machado presents a revision of evidence that support the use of Trimetazidine 80mg for the upbringing of patients that suffer from coronary chronic syndrome.
The doctor explains its metabolic effect, considering a synergy and complimentary action with Beta blockers, offering a significative improvement on the ejection fraction and the LVLGS (Left Ventricular Longitudinal Global Strain) among others. For more information, watch the video ahead:
CAC-05/23-DM-182- For exclusive use of Healthcare professionals
Don't miss our next events!
Subscribe to our newsletter to receive invitations to upcoming events